Printer Friendly
The Free Library
19,573,952 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Celanese Announces Changes to Board of Directors; Elects Walters as New Member.


DALLAS -- Celanese Corporation (NYSE NYSE

See: New York Stock Exchange
: CE), a global hybrid chemical company, today announced that Farah M. Walters has been elected to the Celanese board of directors. Walters is currently president and chief executive officer of QualHealth LLC (Logical Link Control) See "LANs" under data link protocol.

LLC - Logical Link Control
, a company specializing in the design of health care delivery systems to improve quality and cost-effectiveness.

Walters also serves on the board of directors and is lead director for PolyOne Corporation, an NYSE-listed specialty chemical A Specialty chemical is a chemical produced for a specialized use. They are produced in lower volume than bulk chemicals, of which petrochemicals, made from oil feedstocks, are the most common. However, both are produced in a chemical plant.  company. She chairs the company's governance and compensation committees and serves on the financial policy committee.

Previously, Walters served on the board of Kerr-McGee Corporation, an NYSE-listed oil and gas exploration and production company. She served on the company's executive committee, chaired the compensation committee and was a member of the audit and governance committees. She was also a former chair of the audit committee. Walters also previously served on the board of directors of Alpharma Inc., an NYSE-listed pharmaceutical company.

Walters was president and chief executive officer of both University Hospitals Health System, Inc. and University Hospitals of Cleveland University Hospitals is a major not-for-profit medical center in Cleveland, Ohio, United States. With 150 locations throughout northeast Ohio, it encompasses a network of hospitals, outpatient centers and primary care physicians.  from 1992 to 2002.

Celanese also announced that Anjan Mukherjee and James A. Quella, both with The Blackstone Group Blackstone Group L.P. (NYSE: BX) is a prominent private equity and investment management firm founded in 1985 by Peter G. Peterson and Stephen A. Schwarzman. The company is based in New York City, in River House on Park Avenue at Fifty-first Street, with offices in Atlanta,  L.P., resigned from the Celanese board of directors effective May 31, 2007. Mukherjee and Quella resigned from the Celanese board of directors due to the recent public sale by funds affiliated with The Blackstone Group, L.P. of all Celanese shares owned by Blackstone and its affiliates.

About Celanese:

As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America North America, third largest continent (1990 est. pop. 365,000,000), c.9,400,000 sq mi (24,346,000 sq km), the northern of the two continents of the Western Hemisphere. , Europe and Asia. Net sales Net Sales

The amount a seller receives from the buyer after costs associated with the sale are deducted.

Notes:
This amount is calculated by subtracting the following items from gross sales: merchandise returned for credit, allowances for damaged or missing goods, freight
 totaled $6.7 billion in 2006, with over 60% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,900 employees worldwide. For more information on Celanese Corporation, please visit the company's website at www.celanese.com.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Jun 1, 2007
Words:338
Previous Article:Introgen Reports Promising Phase 1/2 Clinical Results With INGN 241 in Patients With Advanced Solid Tumors.
Next Article:Sento Receives Nasdaq Notice That It is in Full Compliance with Continued Listing Standards.
Topics:



Related Articles
Foundation-wise, Ol' Blue Eyes was right about 1999.
COUNCIL VOTE TO PRESS SCHOOL BOARD FAILS.
COUNCIL MULLS CHANGES IN JOINT CHARTER PROPOSAL.
DEMONSTRATORS BACK ZACARIAS.
RESISTANCE WEAKENS TO CHARTER VOTE : 3 COUNCIL MEMBERS TO QUIT BALLOT BATTLE.
SUPERINTENDENT FORUMS MARKED BY SCARCITY OF INVITED GUESTS.
Career moves.
Locked out in Illinois: "How can you do that to a community?".

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles